Apr 30 |
Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024
|
Apr 14 |
10 Micro-Cap Healthcare Stocks Insiders Are Buying
|
Apr 12 |
Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying
|
Apr 9 |
Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
|
Apr 8 |
Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data
|
Apr 8 |
Palatin stock jumps 16% on positive Phase 3 data for eye drug
|
Apr 8 |
Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024
|
Mar 14 |
Palatin files to sell 1.92M shares of common stock for holders
|
Feb 28 |
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Feb 28 |
Palatin stock plunges 40% on mixed Phase 3 data for dry eye drug
|